Comparative Efficacy of Saroglitazar and Pioglitazone in Nonalcoholic Fatty Liver Disease Patients: A Bayesian Network Meta-analysis

Background and Aims: Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndrome. Two drugs, saroglitazar (S) and pioglitazone (P), are known to have beneficial effects on metabolic syndrome. This Bayesian network meta-analysis (NMA) was conducted to compare the relative efficacy...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Binayak Sinha, Samit Ghosal, Debasis Datta
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wolters Kluwer Medknow Publications 2024-01-01
Saila:	International Journal of Diabetes and Technology
Gaiak:	nonalcoholic fatty liver disease network meta-analysis pioglitazone saroglitazar surface under the cumulative ranking curve
Sarrera elektronikoa:	https://journals.lww.com/10.4103/ijdt.ijdt_10_24
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!